Table 2.
Differences in clinical and laboratory parameters between patients with and without transplant vasculopathy at follow-up.
| Parameters | Transplant vasculopathy (n = 105) | No transplant vasculopathy (n = 67) | P |
|---|---|---|---|
| Recipient BMI [kg/m2] | 27.1 ± 5.90 | 25.3 ± 5.00 | 0.032* |
| Donor weight [kg] | 77.0 ± 15.3 | 70.8 ± 18.0 | 0.032* |
| Donor age [years] | 35.4 ± 12.3 | 28.2 ± 13.5 | 0.001* |
| Urea [mg/dL] | 37.1 ± 21.0 | 30.5 ± 17.4 | 0.028* |
| Follow-up after HTx [years] | 15.6 ± 5.70 | 11.7 ± 6.30 | < 0.001* |
| Diabetes mellitus | 24 (35.8%) | 22 (21.0%) | 0.032* |
| Osteoporosis | 11 (16.4%) | 5 (4.8%) | 0.010* |
| Platelet aggregation inhibitors | 46 (68.7%) | 38 (36.2%) | < 0.001* |
| Oral anticoagulation | 15 (22.4%) | 11 (10.5%) | 0.032* |
| Diuretics | 49 (73.1%) | 61 (58.1%) | 0.045* |
Data are presented as a mean ± standard deviation or number (percentage);
*
p < 0.05 (significant);
BMI — body mass index; HTx — heart transplantation